Pharmaceuticals Related Topics 
McKinsey and Company
JULY 21, 2022
Insights on Life Sciences Pharmaceuticals JapanPharma companies in Japan have an opportunity to obtain value from real-world evidence using advanced analytics and to better ensure patient outcomes.
McKinsey and Company
AUGUST 4, 2022
Insights on Life Sciences PharmaceuticalsBy building certain functional and leadership skills, pharma companies can not only improve the odds of a successful launch but also strengthen their organizations for the future.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Perficient Digital Transformation
JANUARY 3, 2022
Even without its projected growth, animal health organizations, much like their human pharmaceutical counterparts, often do not have the adequate technology infrastructure to support or streamline their call centers.
Everest Group
MARCH 16, 2023
Digital Compliance VIEW THE FULL REPORT Business Process Services Digital Services Life Sciences Industry Market Insights™ Procurement / Supply Chain BPO digital life sciences SVM
Zinnov
MARCH 3, 2023
A major US pharma company with a global workforce of over 11,000 people across 3 continents wanted to expand their capabilities by building a Center of Excellence (COE) in the Machine learning & Artificial Intelligence domain.
McKinsey and Company
MARCH 17, 2023
Insights on Healthcare Systems & Services Health Care Pharmaceuticals Health care providers United StatesIn the face of industry headwinds, pharmacies can work to make the most of their distinct advantages to meet shifting consumer needs.
McKinsey and Company
JANUARY 27, 2023
Insights on Life Sciences PharmaceuticalsDigital-native start-ups and healthcare incumbents can both play important roles in building and scaling digital therapeutics to improve the management of chronic health conditions.
McKinsey and Company
FEBRUARY 10, 2023
Insights on Life Sciences Pharmaceuticals InnovationPreclinical development can benefit from advances to accelerate innovation, unlock value, and improve quality.
McKinsey and Company
MARCH 21, 2022
Pharmaceutical and life sciences companies can unlock new opportunities, help underserved patients, and build a cycle of trust. Insights on Life Sciences Health care reform Pharmaceuticals
McKinsey and Company
DECEMBER 10, 2021
The CFO of the pharmaceutical company talks about what it took to develop a COVID-19 vaccine. Strategy & Corporate Finance Insights Pharmaceuticals Strategy & Corporate Finance Strategy
McKinsey and Company
JANUARY 31, 2023
Insights on Life Sciences Pharmaceuticals DigitalLife sciences companies are making progress in adopting and deploying digital and analytics. But they can go further and faster by heeding some lessons from the past few years.
McKinsey and Company
MARCH 13, 2023
Insights on Life Sciences Pharmaceuticals Medical productsGrowth in China’s buoyant medtech market is tapering as policy uncertainties persist. Five approaches to refocus commercial operations can help navigate these challenges.
McKinsey and Company
SEPTEMBER 20, 2022
Roche Pharmaceuticals’ approach to rare conditions highlights industry efforts to make a difference for patients, their caregivers, and healthcare professionals. Insights on Life Sciences Pharmaceuticals Medical products
McKinsey and Company
JANUARY 5, 2023
Insights on Life Sciences PharmaceuticalsGrowth in the availability and variety of real-world data, including nonhealth sources of data, opens up new opportunities, as well as challenges, in their application to real-world evidence and improving health outcomes.
McKinsey and Company
DECEMBER 21, 2021
Insights on Life Sciences PharmaceuticalsThe COVID-19 pandemic has prompted pharma companies to rethink their organizational strategies. A survey of executives suggests where value might lie.
McKinsey and Company
OCTOBER 14, 2022
Public & Social Sector Insights Public health Public & Social Sector Pharmaceuticals Europe North and Central AmericaThe COVID-19 pandemic has highlighted the need for resilience in vaccine manufacturing. Five considerations can help national public-health leaders plan.
McKinsey and Company
SEPTEMBER 23, 2021
Pharmaceutical supply chains have become global and complex. Insights on Life Sciences Pharmaceuticals Supply chain managementWith more outsourcing, new modalities, and novel ways to reach patients, it’s critical to ensure that they can withstand shocks.
McKinsey and Company
MARCH 28, 2023
Insights on Life Sciences PharmaceuticalsA McKinsey survey of more than 1,900 medtech leaders shows that their customers want more omnichannel engagement. We describe five ways medtech companies can respond.
McKinsey and Company
APRIL 8, 2022
Insights on Healthcare Systems & Services Health care providers PharmaceuticalsThe healthcare sector is examining how to better hire and promote women to the highest levels.
McKinsey and Company
JANUARY 27, 2023
Insights on Life Sciences Pharmaceuticals Digital strategy and organizationDigital and analytics can markedly improve life sciences companies’ engagement with customers.
McKinsey and Company
AUGUST 3, 2022
Insights on Life Sciences Health Care Pharmaceuticals DigitalFor life science companies to meet their digital ambitions, they must strengthen their technology skills. In a challenging market, emphasizing value propositions can attract first-rate talent.
McKinsey and Company
OCTOBER 27, 2022
Insights on Life Sciences Health Care PharmaceuticalsThe biopharmaceutical industry has made remarkable achievements in the past decade, but is it equipped to leap still further ahead in the coming one? Company leaders’ answers to nine questions could prove decisive.
McKinsey and Company
JANUARY 10, 2022
Pharmaceutical and medical-device companies can get the most value from “smart quality” processes enabled with new technologies by adopting a holistic approach to building culture and capabilities. Insights on Life Sciences Pharmaceuticals Leadership Strategy
McKinsey and Company
SEPTEMBER 14, 2022
Insights on Life Sciences Pharmaceuticals Performance transformationLife sciences companies pursuing a step change in performance have obtained mixed results. Adhering to five principles can greatly improve the odds of a large transformation program succeeding.
McKinsey and Company
JANUARY 10, 2023
Insights on Life Sciences PharmaceuticalsThe world will need more sterile products than manufacturers have or can build capacity for. But they can create capacity and take market share by running higher volumes through their existing lines.
McKinsey and Company
MARCH 15, 2022
Insights on Life Sciences Pharmaceuticals AnalyticsAs pharma companies apply advanced analytics to generate new types of evidence, how do they decide which use cases to target and how to scale them up across the business?
McKinsey and Company
JANUARY 10, 2023
Insights on Life Sciences Health care services Pharmaceuticals Europe Climate changeAdvances in biological science could help the world overcome its most pressing challenges in health and sustainability. Europe’s Bio Revolution could translate scientific strengths into impact.
McKinsey and Company
APRIL 15, 2022
Insights on Life Sciences Health care services Health Care PharmaceuticalsHealth data platforms that participants trust could bring an end to today’s reductionist approach to drug development, revolutionizing our understanding of disease.
McKinsey and Company
SEPTEMBER 17, 2022
Insights on Life Sciences Pharmaceuticals InnovationThe sometimes-overlooked function of chemistry, manufacturing, and controls (CMC) has a rare opportunity to reimagine its role and find innovative ways to improve and accelerate drug development.
McKinsey and Company
DECEMBER 14, 2022
Insights on Life Sciences Medical products PharmaceuticalsAs the life sciences industry is tested by an uncertain economic environment, companies can focus not only on resilience but on positioning themselves to accelerate when coming out of the downturn.
McKinsey and Company
DECEMBER 19, 2022
Digital Insights Pharmaceuticals Disruptive Technology Analytics DigitalClemens Utschig-Utschig discusses how his company is exploring quantum computing for its potential to propel next-generation drug discovery.
McKinsey and Company
FEBRUARY 15, 2023
Insights on Life Sciences Pharmaceuticals Performance transformationMany biotechs struggle with growing pains as they near their first product launch. The transition to commercial success may require shifts in organization, processes, capabilities, and mindsets.
McKinsey and Company
SEPTEMBER 16, 2021
Insights on Life Sciences PharmaceuticalsBy rethinking the approach to regulatory submissions, pharma companies can reduce timelines and increase their chances of successful product approvals.
McKinsey and Company
AUGUST 15, 2022
Insights on Life Sciences PharmaceuticalsChina-originated biopharmas will likely have greater influence on the industry by 2028, but regulatory developments and the quality of partnerships will determine how the industry grows.
McKinsey and Company
MAY 31, 2022
Insights on Life Sciences PharmaceuticalsPfizer’s Chief Digital and Technology Officer explains how digital is transforming her organization’s ability to bring new medicines to patients at speed and at scale.
McKinsey and Company
MAY 31, 2022
Insights on Life Sciences Pharmaceuticals Biotechnology Artificial IntelligenceBiopharma companies’ pipelines are full of assets they source externally to access innovation. Four practices will help ensure their investments flourish at a time of fierce competition.
McKinsey and Company
NOVEMBER 29, 2021
Insights on Life Sciences Pharmaceuticals Supply chain managementClinical trials have increased in number and have become more complex, decentralized, and patient-centric. While this puts pressure on clinical drug supply, it also brings new opportunities.
McKinsey and Company
OCTOBER 10, 2022
Insights on Operations Pharmaceuticals Operations strategy Manufacturing operationsTo maintain profitable and resilient operations, CEOs and COOs of pharma companies may need to make bold changes to their operations strategy as the industry navigates new challenges.
Ms Category Management
AUGUST 22, 2019
[…] you may know from one of my blogs, “Why Paying Doctors and Nurses Good Thing,” I am in support of the marketing efforts we have for Physicians. Because in short, if […
McKinsey and Company
OCTOBER 10, 2022
Insights on Life Sciences PharmaceuticalsBy focusing on specific scientific and operational pain points and fully integrating AI into research workflows, biopharma companies can deliver greater patient impact and significant value.
McKinsey and Company
OCTOBER 29, 2021
Insights on Life Sciences Pharmaceuticals Medical products ChinaChinese biopharma is making a mark on the global stage as the rapidly evolving regulatory landscape and maturing innovation ecosystem spur significant value creation.
McKinsey and Company
DECEMBER 2, 2021
Insights on Life Sciences Medical products PharmaceuticalsBiopharma companies should consider a new, integrated approach to evidence-generation strategies to better demonstrate the value of therapies to all stakeholders.
McKinsey and Company
MARCH 29, 2022
Insights on Life Sciences PharmaceuticalsViral-vector gene therapies are here to stay. Keeping pace with increasing demand requires consideration of challenges, the potential for standardization, and strategizing for accelerating patient access.
Expert insights. Personalized for you.
104 
Let's personalize your content